News & Press Releases

Retail and Consumer Products Co-chair Charles Samuels was quoted by The Bond Buyer in an article about tax policy trends in 2025.

The M&A landscape in the pharmaceutical industry has shifted significantly since the pandemic. International Life Sciences Chair Cheryl Reicin shares insights in a Pharmaceutical Executive Q&A, discussing the pandemic’s lasting impact on dealmaking trends and the acquisitions poised to gain momentum in 2025.

Of Counsel Michelle Capezza was quoted by Fiduciary News in an article about the potential repercussions of the Johnson v. Parker-Hannifin case over alleged failures to correctly monitor investments, leading to high-cost share classes. Michelle discusses the case’s implications for professional fiduciaries and 401k plan sponsors.

Toronto Office Manager Partner Mitch Frazer was quoted by Benefits Canada in an article about the Canadian federal government’s decision to transfer $1.9 billion surplus from the Public Service Pension Plan to its general revenue. 

ESG Co-chair Jennifer Rubin spoke with The Washington Post about a recent Fifth Circuit opinion, which struck down a Nasdaq rule aiming to encourage diversity on corporate boards. Jen shares that companies can still decide whether they want to provide board diversity information and how the ruling highlights the vast influence of board members on businesses.

An article by Intellectual Property Division Chair Michael Renaud and Member Adam Rizk was recently published by IAM, focused on the critical steps entrepreneurs and other business leaders should take to develop a robust IP strategy to best protect and monetize disruptive technology assets.